ClassID:

21647

A61K2300/00 - page 43 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#12601
20100069289
2010-03-18

ANIMAL FEEDS AND VETERINARY COMPOSITIONS

#12602
20100068347
2010-03-18

NUTRACEUTICAL SWEETENER COMPOSITION

#12603
20100068314
2010-03-18

Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof

#12604
20100068313
2010-03-18

Cranberry seed oil extract and compositions containing components thereof

#12605
20100068308
2010-03-18

Regulation of GSK-3alpha activity for the treatment or prevention of Alzheimer's disease

#12606
20100068306
2010-03-18

COMPOSITIONS FOR ACCELERATING THE HEALING RESPONSE

#12607
20100068304
2010-03-18

COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING CARDIOVASCULAR DISEASES IN FELINES WITH HYPERTHYROIDISM

#12608
20100068303
2010-03-18

Treatment of cancer with bio and chemotherapy

#12609
20100068302
2010-03-18

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER

#12610
20100068301
2010-03-18

COMPOSITIONS AND TREATMENTS COMPRISING 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITORS AND NITRIC OXIDE MODULATORS

#12611
20100068300
2010-03-18

Use of L-carnitine for the preparation of a medicament in the form of eye-drops for treating corneal diseases

#12612
20100068288
2010-03-18

MIXTURES OR ORGANIC COMPOUNDS FOR THE TREATMENT OF AIRWAY DISEASES

#12613
20100068284
2010-03-18

Stable fixed dose topical formulation

#12614
20100068281
2010-03-18

Methods and compositions for tissue regeneration

#12615
20100068273
2010-03-18

PHARMACEUTICAL FORMULATION, ITS USE, AND METHOD FOR ITS MANUFACTURE

#12616
20100068269
2010-03-18

TREATMENT AND PREVENTION OF CARDIOVASCULAR EVENTS

#12617
20100068267
2010-03-18

COMPOSITIONS FOR TREATING VASCULAR DISEASES CHARACTERIZED BY NITRIC OXIDE INSUFFICIENCY

#12618
20100068260
2010-03-18

Methods, Compositions and Device for Directed and Controlled Heating and Release of Agents

#12619
20100068206
2010-03-18

Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of mantle cell lymphomas

#12620
20100068202
2010-03-18

METHOD OF TREATING HEMOLYTIC DISEASE

#12621
20100068192
2010-03-18

Method for Production of T Cell Population

#12622
20100068182
2010-03-18

Combination therapy for treating HCV infection

#12623
20100068177
2010-03-18

Methods of organ regeneration using Hox11-expressing pluripotent cells

#12624
20100068174
2010-03-18

COMBINATION WITH BIS (THIOHYDRAZIDE AMIDES) FOR TREATING CANCER

#12625
20100068173
2010-03-18

Recombinant human albumin-interleukin-11 fusion protein with long-lasting biological effects

#12626
20100068149
2010-03-18

Use of nutritional compositions for preventing disorders

#12627
20100063152
2010-03-11

Method and topical formulation for treating localized edema

#12628
20100063148
2010-03-11

Pharmaceutical Combination

#12629
20100063141
2010-03-11

Deuterated benzylbenzene derivatives and methods of use

#12630
20100063112
2010-03-11

POLYMORPH III OF 4-[4-(AMINO)-3-FLUOROPHENOXY]-N-METHYLPYRIDINE-2-CARBOXAMIDE

#12631
20100063094
2010-03-11

METHODS FOR TREATMENT OF COLORECTAL CANCER USING 3-(4-AMINO-1-OXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE

#12632
20100063093
2010-03-11

METHODS FOR THE ADMINISTRATION OF ILOPERIDONE

#12633
20100063071
2010-03-11

THERAPEUTIC COMPOSITIONS AND RELATED METHODS OF USE

#12634
20100063070
2010-03-11

COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS

#12635
20100063060
2010-03-11

Therapeutic agent for glaucoma comprising Rho Kinhase inhibitor and prostaglandin

#12636
20100063047
2010-03-11

AMINOPYRIMIDINE INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE

#12637
20100063019
2010-03-11

Low Dose Estrogen Interrupted Hormone Replacement Therapy

#12638
20100063017
2010-03-11

Ophthalmic Suspension for Ocular Use

#12639
20100063016
2010-03-11

Pharmaceutical Combinations

#12640
20100063015
2010-03-11

Skin-care preparations containing mupirocin and betamethasone dipropionate

#12641
20100063014
2010-03-11

Drug comprising at least one gestagen

#12642
20100063012
2010-03-11

Compositions and methods for the treatment of inflammatory diseases

#12643
20100063009
2010-03-11

Pharmaceutical Combination Comprising 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1.3-diol and an NSAID

#12644
20100063005
2010-03-11

Methods for Treating Cystic Fibrosis or Pneumonia with Bacterial Infection via Pulmonary Administration of Fosfomycin

#12645
20100062991
2010-03-11

1,4-benzothiepin-1,1-dioxide derivatives which are substituted with fluorine, method for producing the same, drugs containing said compounds and use thereof

#12646
20100062981
2010-03-11

USE OF FIBRINOGEN AS A PROPHYLACTIC TREATMENT TO PREVENT BLEEDING DURING AND AFTER SURGERY AND AS A BIOMARKER TO IDENTIFY PATIENT WITH AN INCREASED RISK FOR EXCESSIVE BLEEDING AND BLOOD TRANSFUSION

#12647
20100062979
2010-03-11

TREATMENT OF ECTOPARASITIC INFESTATION

#12648
20100062974
2010-03-11

Combination therapy for the treatment of bacterial infections

#12649
20100062113
2010-03-11

HYDROGEN-DISSOLVED AQUEOUS SOLUTION AND METHOD FOR PROLONGING THE LIFE DURATION OF HYDROGEN DISSOLVED IN THE AQUEOUS SOLUTION

#12650
20100062090
2010-03-11

Pharmaceutical composition comprising metadoxine and garlic oil for preventing and treating alcohol-induced fatty liver and steatohepatitis

#12651
20100062088
2010-03-11

COMPOSITIONS COMPRISING KAKADU PLUM EXTRACT OR ACAI BERRY EXTRACT

#12652
20100062087
2010-03-11

Nutraceutical Treatments for Diabetic and Non-Diabetic Wound Healing

#12653
20100062081
2010-03-11

Use of tellurium containing compounds as nerve protecting agents

#12654
20100062078
2010-03-11

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER AND THE SIGNALING PATHWAY THEREOF

#12655
20100062074
2010-03-11

Allergen inactivating agent

#12656
20100062064
2010-03-11

Method for delivering a pharmaceutical composition to patient in need thereof

#12657
20100062060
2010-03-11

Pharmaceutical composition comprising tramadol and ketoprofen in association

#12658
20100062059
2010-03-11

S-Nitrosothiols Containing Composition for the Treatment of Fatty Liver Diseases, Obesity and Other Diseases Associated with the Metabolic Syndrome and the Use of Such Compositions

#12659
20100062053
2010-03-11

Cholestanol derivative for combined use

#12660
20100061999
2010-03-11

ANTIHUMAN TNF-ALPHA ANTIBODY ACTIVITY LOWERING INHIBITOR

#12661
20100061984
2010-03-11

COMPOSITIONS AND METHODS FOR MODULATION OF SUPPRESSOR T CELL ACTIVATION

#12662
20100061975
2010-03-11

Uses for 4,17β-dihydroxyandrost-4-ene-3-one

#12663
20100061970
2010-03-11

CBLB for treating endotoxin-mediated disorders

#12664
20100061968
2010-03-11

Reducing cholesterol levels with combined use of quercetin and statin

#12665
20100061958
2010-03-11

Modulation of Regulatory T Cells by Human IL-18

#12666
20100057218
2010-03-04

Methods of administering a material into a patient for dermal enhancement

#12667
20100056974
2010-03-04

Bone metabolism improving agent

#12668
20100056762
2010-03-04

SPECIFIC BINDING PROTEINS AND USES THEREOF

#12669
20100056761
2010-03-04

ANTIBODIES AGAINST ERBB3 AND USES THEREOF

#12670
20100056643
2010-03-04

CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA

#12671
20100056625
2010-03-04

Non-toxic anti-cancer drug combining ascorbate, magnesium and a naphthoquinone

#12672
20100056606
2010-03-04

Combination therapy using budesonide and antisense oligonucleotide targeted to IL4-receptor alpha

#12673
20100056564
2010-03-04

Association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent

#12674
20100056560
2010-03-04

USE FOR TREATING OBESITY AND DIABETES

#12675
20100056559
2010-03-04

PROPELLANT-FREE AEROSOL FORMULATION FOR INHALATION

#12676
20100056552
2010-03-04

COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS

#12677
20100056540
2010-03-04

STABLE PHARMACEUTICAL COMPOSITION FOR OPTIMIZED DELIVERY OF AN HIV ATTACHMENT INHIBITOR

#12678
20100056536
2010-03-04

METHOD OF TREATING ATRIAL FIBRILLATION

#12679
20100056529
2010-03-04

Substituted triazolo-pyridazine derivatives

#12680
20100056521
2010-03-04

(Aza)indole derivative and use thereof for medical purposes

#12681
20100056486
2010-03-04

COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND CORTICOSTEROIDS

#12682
20100056485
2010-03-04

NANOSOAP CONTAINING SILVER NANOPARTICLES

#12683
20100056467
2010-03-04

Combination of IAP inhibitors and FLT3 inhibitors

#12684
20100056463
2010-03-04

Compositions

#12685
20100056460
2010-03-04

COMBINATION OF ORGANIC COMPOUNDS

#12686
20100056454
2010-03-04

Method for screening modulators of apoptosis

#12687
20100056430
2010-03-04

Treatment and Method for Eliminating or Reducing Foot Odor

#12688
20100056426
2010-03-04

USE OF IRON CHELATOR FOR THE TREATMENT OF MYOCARDIAL INFARCTION

#12689
20100056425
2010-03-04

Absorption enhancers such as E.G. BHT, BHA or propyl gallate

#12690
20100055230
2010-03-04

PRODUCT AND PROCESS FOR ELEVATING LIPID BLOOD LEVELS IN LIVESTOCK

#12691
20100055218
2010-03-04

NOVEL COMPOSITIONS

#12692
20100055216
2010-03-04

Pharmaceutical composition for inhibiting the syndrome of snoring and preparation thereof

#12693
20100055213
2010-03-04

Composition comprising the extract of crude drug complex having neuroprotective activity for preventing and treating stroke and neurodegenerative diseases

#12694
20100055206
2010-03-04

Use of ribose in first response to acute myocardial infarction

#12695
20100055201
2010-03-04

Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles

#12696
20100055185
2010-03-04

COMPOSITION AND METHOD FOR TREATING HEMORRHOIDS AND/OR ANORECTAL DISORDERS

#12697
20100055183
2010-03-04

TRIMEPRAZINE AND ETHOPROPAZINE DERIVATIVES FOR PROMOTING BONE GROWTH

#12698
20100055182
2010-03-04

Use of guanidinoacetic acid (salts) combination with betaine and/or choline to produced an agent that is beneficial to health

#12699
20100055167
2010-03-04

STEM CELL DELIVERY OF ANTI-NEOPLASTIC MEDICINE

#12700
20100055152
2010-03-04

ANTIHISTAMINE AND ANTIHISTAMINE-LIKE NASAL APPLICATION, PRODUCTS, AND METHOD

#12701
20100055138
2010-03-04

METHODS AND TOPICAL FORMULATIONS COMPRISING COLLOIDAL METAL FOR TREATING OR PREVENTING SKIN CONDITIONS

#12702
20100055102
2010-03-04

Compositions of PD-1 antagonists and methods of use

#12703
20100055094
2010-03-04

Pharmaceutical combinations of 1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea

#12704
20100055077
2010-03-04

METHODS FOR INCREASING AND MOBILIZING HEMATOPOIETIC STEM CELLS

#12705
20100055073
2010-03-04

TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDERS

#12706
20100055072
2010-03-04

2-oxo-1,2-dihydro-quinoline modulators of immune function

#12707
20100055059
2010-03-04

ASSOCIATION OF COMPOUNDS INHIBITING MELANOGENESIS AND USE THEREOF IN COSMETICS AND DERMATOLOGY

#12708
20100055056
2010-03-04

AGENT FOR IMPROVING PERMEATION OF A DRUG INTO A NAIL AND AN EXTERNAL TREATING AGENT CONTAINING THE SAME

#12709
20100055046
2010-03-04

Composition and method for treating colds

#12710
20100051025
2010-03-04

Attenuation of vasoactive oxygen carrier-induced vasoconstriction

#12711
20100048763
2010-02-25

Bone cement compositions having fiber-reinforcement and/or increased flowability

#12712
20100048725
2010-02-25

Use of cyclopamine in the treatment of basal cell carcinoma and other tumors

#12713
20100048704
2010-02-25

PHARMACEUTICAL AND NUTRACEUTICAL PRODUCTS COMPRISING VITAMIN K2

#12714
20100048691
2010-02-25

Method useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance

#12715
20100048688
2010-02-25

Dietary and pharmaceutical compositions containing carnosol and/or rosmanol and their uses

#12716
20100048683
2010-02-25

Modified vaccinia virus ankara for the vaccination of neonates

#12717
20100048659
2010-02-25

Aqueous compositions containing metronidazole

#12718
20100048649
2010-02-25

COMBINATIONS COMPRISING BICYCLIC S1P LYASE INHIBITORS

#12719
20100048630
2010-02-25

METHODS FOR TREATING CNS DISORDERS

#12720
20100048627
2010-02-25

Synergistic pharmaceutical combination for the prevention or treatment of diabetes

#12721
20100048621
2010-02-25

MEDICAMENT FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE

#12722
20100048616
2010-02-25

COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS

#12723
20100048615
2010-02-25

COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS

#12724
20100048605
2010-02-25

SYNERGISTIC EFFECTS OF COMBINATIONS OF NORNICOTINE AND OPIOIDS FOR THE TREATMENT OF PAIN

#12725
20100048542
2010-02-25

Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)

#12726
20100048538
2010-02-25

Therapeutical Uses of Eslicarbazepine

#12727
20100048528
2010-02-25

HETEROCYCLIC COMPOUNDS AS INHIBITORS OF BETA-LACTAMASES

#12728
20100048521
2010-02-25

COMBINATION OF A GLUCO-KORTICOID AND BETA-CYCLODEXTRIN CONJUGATED VITAMIN A-DERIVATE COMPLEX

#12729
20100048520
2010-02-25

Rifaximin anti-rectal dysfunction preparation

#12730
20100048518
2010-02-25

Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent

#12731
20100048508
2010-02-25

Mixture and method for reducing cholesterol using hydrophobic microparticles

#12732
20100048503
2010-02-25

COMPOSITION FOR TREATMENT OF PANCREATIC CANCER

#12733
20100048500
2010-02-25

Anti-viral nucleoside analogs and methods for treating viral infections, especially HIV infections

#12734
20100048484
2010-02-25

Methods for treating diabetic wounds

#12735
20100048475
2010-02-25

Method of treating dyspnea associated with acute heart failure

#12736
20100048461
2010-02-25

Methods of use of Trk receptor modulators

#12737
20100048454
2010-02-25

Antidiabetic oral insulin-biguanide combination

#12738
20100047369
2010-02-25

Anti-tumor drug, medicament, composition, and use thereof

#12739
20100047364
2010-02-25

Nutrient System for Individualized Responsive Dosing Regimens

#12740
20100047363
2010-02-25

NUTRITIONAL SUPPLEMENT FOR PATIENTS WITH CHRONIC KIDNEY DISEASE

#12741
20100047357
2010-02-25

COMPOSITIONS FOR TOPICAL APPLICATION COMPRISING A PEROXIDE AND RETINOID

#12742
20100047352
2010-02-25

COMPOSITIONS AND METHODS FOR TREATING EXCESSIVE BLEEDING

#12743
20100047344
2010-02-25

Performance enhancing composition and use thereof

#12744
20100047341
2010-02-25

COMBINED PREPARATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BASED ON CHRONOTHERAPY THEORY

#12745
20100047339
2010-02-25

Compositions for the treatment of chronic degenerative inflammatory conditions

#12746
20100047330
2010-02-25

TREATMENT FOR DARK ADAPTATION

#12747
20100047322
2010-02-25

Combination antihypertensive wafer

#12748
20100047314
2010-02-25

FOLINIC ACID DERIVATIVES FOR PROMOTING BONE GROWTH

#12749
20100047288
2010-02-25

Hybrid cells for treating cancer patients

#12750
20100047234
2010-02-25

TREATING SKIN CANCER

#12751
20100047231
2010-02-25

Immuno-Stimulant Combination for Prophylaxis and Treatment of Hepatitis C

#12752
20100047227
2010-02-25

NOVEL ANTICANCER CATHEPSIN FORMULATIONS AND ANTICANCER AGENT FOR USE IN COMBINED ANTICANCER THERAPY

#12753
20100047223
2010-02-25

Pharmanutrient Composition(s) and System(s) for Individualized, Responsive Dosing Regimens

#12754
20100047215
2010-02-25

STEM CELL TARGETING METHODS

#12755
20100047207
2010-02-25

Therapeutic Composition To Improve The Effect Of The Therapy With Anti-Epidermal Growth Factor Receptor Antibodies

#12756
20100047205
2010-02-25

Vaccine immunotherapy

#12757
20100047181
2010-02-25

MIXTURE OF A VANILLOID RECEPTOR AGONIST AND A SUBSTANCE INHIBITING NERVE REGENERATION, USE THEREOF FOR PRODUCING A PAINKILLER, AND METHOD FOR APPLYING SAID PAINKILLER

#12758
20100047177
2010-02-25

METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIES

#12759
20100047167
2010-02-25

COMBINATION THERAPY IN THE TREATMENT OF CANCER

#12760
20100043788
2010-02-25

Devices and methods for minimizing and treating high-altitude sickness

#12761
20100041751
2010-02-18

Method to Reduce Oxidative Damage and Improve Mitochondrial Efficiency

#12762
20100041725
2010-02-18

Stable pharmaceutical composition

#12763
20100041691
2010-02-18

PHARMACEUTICAL COMPOSITIONS COMPRISING COMBINATIONS OF AN AMPA/KAINATE ANTAGONISTIC COMPOUND AND AN INHIBITOR OF A MULTIDRUG RESISTANCE PROTEIN

#12764
20100041690
2010-02-18

Co-Administration of Dopamine-Receptor Binding Compounds

#12765
20100041689
2010-02-18

Combined Effects of Topiramate and Ondansetron on Alcohol Consumption

#12766
20100041679
2010-02-18

ORAL DIETING COMPOSITION COMPRISING CONJUGATED LINOLEIC ACID AND CAFFEINE

#12767
20100041678
2010-02-18

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISORDERS

#12768
20100041677
2010-02-18

Inhibitors of Bruton's tyrosine kinase

#12769
20100041671
2010-02-18

Methods for treating glaucoma

#12770
20100041668
2010-02-18

Compositions and methods for treating thrombocytopenia

#12771
20100041620
2010-02-18

METHODS FOR IMPROVING FRONTAL BRAIN BIOENERGETIC METABOLISM

#12772
20100041619
2010-02-18

Lasonolide compounds as reagents for inducing premature chromosome condensation and methods for treating disorders

#12773
20100041613
2010-02-18

NOVEL ANTIBIOTIC COMPOSITIONS

#12774
20100041606
2010-02-18

Methods of Use of Eggshell Polypeptides

#12775
20100041605
2010-02-18

Use of VEGF-C or VEGF-D in Reconstructive Surgery

#12776
20100041602
2010-02-18

Methods for treating immune disorders associated with graft transplantation with soluble CTLA4 mutant molecules

#12777
20100041587
2010-02-18

COMBINATION THERAPY FOR INHIBITION OF PLATELET AGGREGATION

#12778
20100041147
2010-02-18

HEMOGLOBIN ALPHA CHAIN PEPTIDE FRAGMENTS USEFUL FOR INHIBITING STEM CELL PROLIFERATION

#12779
20100040712
2010-02-18

THROAT SPRAY

#12780
20100040710
2010-02-18

Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers.

#12781
20100040707
2010-02-18

INGESTIBLE COMPOSITIONS CONTAINING EXTRACTS

#12782
20100040701
2010-02-18

COMPOUND FOR EXFOLIATING SKIN

#12783
20100040700
2010-02-18

Kit for promoting hair growth

#12784
20100040689
2010-02-18

Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders

#12785
20100040686
2010-02-18

BIOMATERIAL

#12786
20100040679
2010-02-18

Compositions for Reducing Nicotine Withdrawal Symptoms and/or Tobacco Usage

#12787
20100040669
2010-02-18

Non-Invasive Ocular Delivery of Rapamycin

#12788
20100040668
2010-02-18

Biomimetic Hydroxyapatite Composite Materials and Methods for the Preparation Thereof

#12789
20100040632
2010-02-18

COMPOSITION

#12790
20100040631
2010-02-18

Highly potent synergistic combinations of human immunodeficiency virus (HIV) fusion inhibitors

#12791
20100040630
2010-02-18

METHODS AND COMPOSITIONS FOR TREATING BONE LOSS

#12792
20100040620
2010-02-18

ANTI-CANCER ANTIBODIES AGAINST LEWISy AND LEWISb ANTIGENS

#12793
20100040614
2010-02-18

COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS

#12794
20100040607
2010-02-18

Combination Therapy with Inhibitors of HMGB and Caspase for the Treatment of Inflammatory Diseases

#12795
20100040603
2010-02-18

Methods for promoting protection and regeneration of bone marrow using CXCL9 and anti-CXCL9 antibodies

#12796
20100040598
2010-02-18

KIT OF PARTS COMPRISING AN ACID LABILE AND AN ACID RESISTANT PHARMACEUTICALLY ACTIVE INGREDIENT

#12797
20100040596
2010-02-18

USE OF MATRIX METALLOPROTEINASE-10 (MMP-10) FOR THROMBOLYTIC TREATMENTS

#12798
20100040592
2010-02-18

LIPASE-CONTAINING COMPOSITION AND METHODS OF USE THEREOF

#12799
20100040581
2010-02-18

EPO DERIVATIVE-CONTAINING THERAPEUTIC AGENTS FOR BLOOD-RELATED DISEASES

#12800
20100040568
2010-02-18

Steroidal compounds as melanogenesis modifiers and uses thereof

#12801
20100036107
2010-02-11

RNA INTERFERENCE COMPOSITIONS AND METHODS

#12802
20100035998
2010-02-11

COMBINATION S-NITROSOTHIOL PHARMACEUTICAL PRODUCTS FOR RESTORING NORMAL BREATHING RHYTHMS

#12803
20100035992
2010-02-11

Methods and Compositions for Treating Inflammation and Inflammation-Related Pathologies

#12804
20100035979
2010-02-11

Compositions and methods of sensitizing methicillin resistant to beta-lactam antibiotics

#12805
20100035978
2010-02-11

COMBINATION OF CANNABINOIDS FOR THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN

#12806
20100035973
2010-02-11

DISRUPTION OF PROGRAMMED DEATH 1 (PD-1) LIGAND TO ADJUVANT ADENO-ASSOCIATED VIRUS VECTOR VACCINES

#12807
20100035961
2010-02-11

1,4-benzothiepine 1,1-dioxide derivatives substituted by benzyl radicals, method for their preparation, pharmaceuticals comprising these compounds, and the use thereof

#12808
20100035939
2010-02-11

Penetrating carrier, anti-fungal composition using the same and method for treatment of dermatophytes

#12809
20100035930
2010-02-11

Urea and sulfamide derivatives as inhibitors of TAFIa

#12810
20100035927
2010-02-11

MEDICAMENT FOR PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF ALZHEIMER-TYPE DEMENTIA

#12811
20100035903
2010-02-11

Pyrrolo[2,3-D]pyrimidine compounds

#12812
20100035896
2010-02-11

Combination of N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide and an anti-mitotic cytotoxic agent

#12813
20100035886
2010-02-11

PARENTERAL FORMULATIONS OF DOPAMINE AGONISTS

#12814
20100035885
2010-02-11

COMPOSITIONS FOR MANIPULATING THE LIFESPAN AND STRESS RESPONSE OF CELLS AND ORGANISMS

#12815
20100035862
2010-02-11

NOVEL AZA-CYCLIC INDOLE-2-CARBOXAMIDES AND METHODS OF USE THEREOF

#12816
20100035860
2010-02-11

INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE FOR THE PROMOTION OF PHYSIOLOGICAL CARDIAC HYPERTROPHY

#12817
20100035858
2010-02-11

Novel Compositions and Methods for Binding and Inhibiting 5-HT4 Receptor

#12818
20100035855
2010-02-11

Method for treating or preventing a cardiovascular disease or condition utilizing estrogen receptor modulators based on APOE allelic profile of a mammalian subject

#12819
20100035853
2010-02-11

METHOD FOR PREVENTING OR TREATING CISPLATIN-INDUCED NEPHROTOXICITY

#12820
20100035848
2010-02-11

THERAPY FOR DISORDERS OF THE PROXIMAL DIGESTIVE TRACT

#12821
20100035824
2010-02-11

Synergistic Pharmaceutical Composition

#12822
20100035816
2010-02-11

Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency or oxidative stress or skin ageing or dry skin

#12823
20100035808
2010-02-11

Methods for promoting organ development

#12824
20100035793
2010-02-11

Modulators

#12825
20100034904
2010-02-11

Composition comprising rutin and polyunsaturated fatty acid having an inhibitory activity on 5 α-reductase

#12826
20100034901
2010-02-11

ANIMAL FEED COMPOSITIONS

#12827
20100034890
2010-02-11

COMBINATIONS OF FORMOTEROL AND FLUTICASONE PROPIONATE FOR ASTHMA

#12828
20100034878
2010-02-11

COMBINATION OF VITAMIN K AND VITAMIN K ANTAGONIST SUCH AS R-ISOMER OF WARFARIN, PHENPROCOUMON OR R-ISOMER OF PHENPROCOUMON AS ANTICOAGULANT THERAPY

#12829
20100034873
2010-02-11

TRANSDERMAL RICINOLEIC ACID COMPOSITIONS

#12830
20100034839
2010-02-11

METHODS FOR TREATING VIRAL DISORDERS

#12831
20100034824
2010-02-11

TARGETED BIOCIDES

#12832
20100034795
2010-02-11

Use of L-carnitine or an alkanoyl L-carnitine, for the preparation of a dietary supplement or medicament for the treatment of corneal disease

#12833
20100034794
2010-02-11

ENDOTHELIAL PROGENITOR CELL COMPOSITIONS AND NEOVASCULARIZATION

#12834
20100034768
2010-02-11

COMPOSITION AND METHOD FOR TREATMENT OF INSECT BITES

#12835
20100029781
2010-02-04

METHODS FOR PREPARATION OF ANTI-ACNE FORMULATION AND COMPOSITIONS PREPARED THEREBY

#12836
20100029780
2010-02-04

TOPICAL COMPOSITION

#12837
20100029779
2010-02-04

Composition and method for treatment of MRSA

#12838
20100029771
2010-02-04

TREATMENT OF ADDICTIVE DISORDERS

#12839
20100029770
2010-02-04

Methods of treating fragile X syndrome and autism

#12840
20100029769
2010-02-04

Topical formulation including diclofenac, or a pharmaceutically acceptable salt thereof

#12841
20100029768
2010-02-04

Compositions and methods for promoting fat loss

#12842
20100029765
2010-02-04

TOPICAL AQUEOUS COMPOSITION COMPRISING TRETINOIN

#12843
20100029762
2010-02-04

Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris

#12844
20100029760
2010-02-04

Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity

#12845
20100029759
2010-02-04

COMPOSITION USEFUL FOR THE TREATMENT OF TYPE 2 DIABETES

#12846
20100029757
2010-02-04

USE OF XANTHOHUMOL AND/OR ISOXANTHOHUMOL AS AN AGENT FOR PREVENTING AND/OR COMBATING LIVER DISEASES

#12847
20100029755
2010-02-04

P-Glycoprotein inhibitor comprising octilonium bromide as an effective ingredient

#12848
20100029744
2010-02-04

Methods for Alzheimer's disease treatment and cognitive enhancement

#12849
20100029732
2010-02-04

Combinations of Beta-2-Adrenoceptor Agonistic Benzothiazolone

#12850
20100029723
2010-02-04

METHODS AND COMPOSITIONS FOR REDUCTION OF SIDE EFFECTS OF THERAPEUTIC TREATMENTS

#12851
20100029708
2010-02-04

1,8-naphthyridine compounds for the treatment of cancer

#12852
20100029674
2010-02-04

Methods of Using Phosphoantigen for the Treatment of Cancer

#12853
20100029665
2010-02-04

Methods and Compositions for Treating Migraine Pain

#12854
20100029663
2010-02-04

Compositions and methods for reducing activation of alpha-1 receptors

#12855
20100029662
2010-02-04

Vasoconstriction compositions and methods of use

#12856
20100029661
2010-02-04

Anesthetic compositions and methods of use

#12857
20100029660
2010-02-04

Compositions and methods for reversing rebound hyperemia

#12858
20100029659
2010-02-04

Preferential vasoconstriction compositions and methods of use

#12859
20100029652
2010-02-04

Combination Therapy For Treating Hepatitis C Infections

#12860
20100029630
2010-02-04

Reverse-turn mimetics and method relating thereto

#12861
20100029604
2010-02-04

ANTIBACTERIAL COMBINATION AND ITS USE

#12862
20100029601
2010-02-04

Administration of fluocinolone acetonide, tretinoin and hydroquinone cream in melasma maintenance therapy

#12863
20100029597
2010-02-04

RecA inhibitors with antibiotic activity, compositions and methods of use

#12864
20100029596
2010-02-04

Method of treating or preventing osteoporosis comprising administering to a patient in need thereof an effective amount of pharmacuetical composition comprising benzamidine derivative or it's salt, and bisphosphonate

#12865
20100029595
2010-02-04

Method of treating or preventing osteoporosis comprising administering to a patient in need thereof an effective amount of pharmaceutical composition comprising benzamidine derivatives or their salts, and alendronic acid or its salt

#12866
20100029591
2010-02-04

Combinations of a pyrimidine containing NNRTI with RT inhibitors

#12867
20100029576
2010-02-04

Diazoxide for the treatment of Friedreich's ataxia

#12868
20100029574
2010-02-04

Cosmetic compositions

#12869
20100029570
2010-02-04

Peptide and treatment for HIV-1 infection

#12870
20100029567
2010-02-04

Method of correcting imbalance between bone resorption and bone formation and kits and compositions therefor

#12871
20100029564
2010-02-04

Solubilized protein composition obtained from eggshell membrane

#12872
20100029559
2010-02-04

Method for achieving desired glial growth factor 2 plasma levels

#12873
20100029557
2010-02-04

ALPHA-LACTALBUMIN COMPOSITION

#12874
20100029551
2010-02-04

Treatment Of Inflammatory Lung Conditions With Aerosolized Macrolide Antibiotics

#12875
20100029543
2010-02-04

Methods for treating nucleoside-induced pain

#12876
20100028922
2010-02-04

IDENTIFICATION AND CHARACTERIZATION OF HCV REPLICON VARIANTS WITH REDUCED SUSCEPTIBILITY TO BENZOFURANS, AND METHODS RELATED THERETO

#12877
20100028473
2010-02-04

Body fat-reducing agent

#12878
20100028464
2010-02-04

USE OF SAFFRON AND/OR SAFRANAL AND/OR CROCIN AND/OR PICROCROCIN AND/OR DERIVATIVES THEREOF AS A SATEITY AGENT FOR TREATMENT OF OBESITY

#12879
20100028460
2010-02-04

IMPROVEMENTS IN RELATION TO CANCER THERAPY

#12880
20100028458
2010-02-04

Mild composition for skin disinfection

#12881
20100028456
2010-02-04

Broad-spectrum antiviral composition with excellent preservation stabilty

#12882
20100028442
2010-02-04

Methods of therapeutic treatment of eyes

#12883
20100028425
2010-02-04

PHARMACEUTICAL COMPOSITION OF ATOVAQUONE

#12884
20100028414
2010-02-04

COMBINATION OF TYROSINE KINASE INHIBITOR AND HER-2/NEU FOR CANCER THERAPY

#12885
20100028413
2010-02-04

SKIN TREATMENT STRIP

#12886
20100028404
2010-02-04

Methods for manufacturing a composition for treating bone and/or cartilage defects

#12887
20100028383
2010-02-04

Chemically defined vaccine stabiliser

#12888
20100028347
2010-02-04

Antibodies against vascular endothelial growth factor receptor-1

#12889
20100028346
2010-02-04

Synergistic effects

#12890
20100028344
2010-02-04

CONDITIONED CELL IMMUNIZATION

#12891
20100028339
2010-02-04

COMPOSITIONS INCLUDING TRICIRIBINE AND TRASTUZUMAB AND METHODS OF USE THEREOF

#12892
20100028338
2010-02-04

Combinations of therapeutic agents for treating cancer

#12893
20100028334
2010-02-04

COMPOSITIONS AND METHODS TO POTENTIATE COLISTIN ACTIVITY

#12894
20100028317
2010-02-04

Skin repair compositions comprising circadian gene activators and a synergistic combination of 1 gene activators

#12895
20100028316
2010-02-04

MODERATING THE EFFECT OF ENDOTOXINS

#12896
20100028299
2010-02-04

Methods and composition of treating a flaviviridae family viral infection

#12897
20100028298
2010-02-04

INTERFERON TYPE I SUPPORTING COMPOUNDS

#12898
20100028297
2010-02-04

COADMINISTRATION OF ALPHA-FETOPROTEIN AND AN IMMUNOMODULATORY AGENT TO TREAT MULTIPLE SCLEROSIS

#12899
20100028274
2010-02-04

ORAL DISINFECTANT, AND FOOD ADDITIVE COMPRISING THE DISINFECTANT

#12900
20100028267
2010-02-04

Compositions and methods for reducing capillary permeability